Literature DB >> 8587261

Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis.

N D Vaziri1, K H Liang.   

Abstract

Increased production and depressed catabolism of lipoproteins play major roles in the pathogenesis of hypercholesterolemia of nephrotic syndrome (NS). However, the effect, if any, of NS on cholesterol biosynthetic capacity is uncertain. We examined the gene expression of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoAR, the rate limiting step in cholesterol biosynthesis) during the induction and chronic phase of puromycin (PAN)-induced NS in rats. The rats were randomized to NS (given i.p. puromycin aminonucleoside 130 mg/kg on day 1 and 60 mg/kg on day 14) and placebo-treated control groups. Subgroups of animals were sacrificed at days 5, 10, 20 and 30. The liver was harvested between 7 and 9 p.m. for measurements of HMG-CoAR and actin mRNAs, HMG-CoAR enzymatic activity and microsomal cholesterol concentration. In separate experiments, subgroups of animals with chronic NS (day 30) were studied in fed and 20-hour fasting states. A marked but transient rise in hepatic HMG-CoAR mRNA and HMG-CoAR enzymatic activity was observed following the onset and exacerbation of proteinuria within a few days after each puromycin injection. On each occasion, HMG-CoAR fell to the baseline level despite persistent severe hypercholesterolemia. In an attempt to examine the possible acute effect of PAN per se, experiments were repeated before and at short intervals (8 and 24 hr) after puromycin injection when proteinuria was absent and the drug exposure prominent. The HMG-CoAR mRNA and activity were virtually unchanged during this period, suggesting the lack of an acute effect of puromycin. Twenty-hour fasting led to a marked rise in HMG-CoAR mRNA and activity in animals with chronic NS but not in the controls. Microsomal cholesterol remained unchanged and comparable in the two groups at all points. Thus, the marked but transient rise in hepatic HMG-CoAR gene expression observed during the induction phase and with fasting during the chronic phase of PAN-induced NS may contribute to the generation and maintenance of hypercholesterolemia in this animal model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587261     DOI: 10.1038/ki.1995.500

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.

Authors:  Mary E Haas; Amy E Levenson; Xiaowei Sun; Wan-Hui Liao; Joseph M Rutkowski; Sarah D de Ferranti; Valerie A Schumacher; Philipp E Scherer; David J Salant; Sudha B Biddinger
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

Review 2.  Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.

Authors:  Nosratola D Vaziri
Journal:  Kidney Int       Date:  2016-04-26       Impact factor: 10.612

Review 3.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

Review 4.  Lipid lowering in renal disease.

Authors:  Alice Kennard; Richard Singer
Journal:  Aust Prescr       Date:  2017-08-01

5.  Bile acid metabolism in analbuminemic rats.

Authors:  A Kambe; K Uchida; H Takase; Y Nomura; Y Adachi
Journal:  Lipids       Date:  1998-01       Impact factor: 1.880

6.  Hepatic cholesterol metabolism in experimental nephrotic syndrome.

Authors:  A al-Shurbaji; E Humble; M Rudling; B Lindenthal; L Berglund
Journal:  Lipids       Date:  1998-02       Impact factor: 1.880

Review 7.  Causes of dysregulation of lipid metabolism in chronic renal failure.

Authors:  Nosratola D Vaziri
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

Review 8.  Cholesterol Metabolism in CKD.

Authors:  Allison B Reiss; Iryna Voloshyna; Joshua De Leon; Nobuyuki Miyawaki; Joseph Mattana
Journal:  Am J Kidney Dis       Date:  2015-09-01       Impact factor: 8.860

9.  Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats.

Authors:  Yunfeng Zhou; Xiaoyan Zhang; Lihong Chen; Jing Wu; Huaixin Dang; Mingfen Wei; Yanbo Fan; Yahua Zhang; Yi Zhu; Nanping Wang; Matthew D Breyer; Youfei Guan
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-09

10.  Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome.

Authors:  Seungyeup Han; Nosratola D Vaziri; Pavan Gollapudi; Vincent Kwok; Hamid Moradi
Journal:  Am J Transl Res       Date:  2013-03-28       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.